Patients’ sources, views and perceptions of
drug information, and the relationship with
drug compliance in a primary care setting
Tammy KW Tam 譚嘉渭,Dominic MW Lau 劉敏維,Kinson KS Lau 劉建生,Kwok-keung Ng 吳國強,
Cecilia YM Fan 范婉雯
HK Pract 2022;44:37-50
Summary
Objective:
We examined patients’ sources, views and
perceptions of drug information and the relationship
with drug compliance in a primary care setting.
Design:
A cross-sectional study using a questionnaire.
Subjects:
Randomly selected subjects aged ≥18
attending clinics during the period from 3 September
2018 through 29 March 2019.
Main outcome measures:
Descriptive statistics of
questionnaire data.
The association between drug compliance and views
and perception of drug information.
Results:
The study recruited 2,165 subjects. The
response rate was 91.5%. The doctor (81.5%) was the
most important source of information. Most concerns
were about side effects of medications (80.2%), how
to administer the drug (56.1%) and drug efficacy
(41.9%). Good drug compliance was associated with
tertiary education (OR 2.17, (95% CI 1.28-3.69)), having
often/ always received drug information (OR 2.08,
(95% CI 1.22-3.54) and OR 6.09, (95% CI 2.37-15.63)
respectively), and agreement that drug information
improves drug compliance (OR 1.90, 95% CI (1.08-
3.35)), and not associated with perception whether or
not drug information was easy to understand or useful.
Conclusions:
The doctor was an important source of
drug information. Side effects of medications, how to
administer the drug and drug efficacy were important
drug information. Good drug compliance was strongly
associated with provision of drug information, regardless
of the perceived understandability or usefulness.
Keywords:
the drug, drug compliance, primary care, patients
摘要
目的 :
研究基層醫療患者的藥物資訊來源,對藥物資訊的
看法和觀念以及與藥物服從性的關係。
設計 :
橫斷面問卷調查。
對象 :
隨機選取2018年9月3日至2019年3月29日期間,到
診所就醫的18歲及以上的患者。
主要結果測量 :
問卷資料的描述性統計分析。藥物依從性與對藥物諮詢的看法、觀念之間的關聯。
研究結果 :
此項研究共有2165名患者參加。問卷的
應答率為91.5%,醫生是最重要的資訊來源(81.5%)。
患者最關心的是藥物的副作用(80.2%),如何用藥
(56.1%)和藥物的療效(41.9%)。
良好的藥物依從性與以下因素有關聯:高等教育程
度OR 2.17 (95% CI 1.28-3.69)。經常或總能獲得藥
物資訊分別為OR 2.08 (95% CI 1. 22-3.54)和OR 6.09
(95% CI 2.37-15.63)。藥物資訊能夠提高服藥的依从
性,OR 1.90 (95% CI 1.08-3.35),但同患者是否容易
理解藥物資訊或者有無帮助並無關聯。
結論 :
醫生是藥物資訊的主要來源。藥物的副作用、
如何用藥和藥物的療效是資訊的主要內容。良好藥物
依從性以是否獲得藥物資訊密切相關,無論其內容是
否容易理解或是對病人有用。
關鍵詞 :
藥物,藥物依從性,基層醫療,患者
Introduction
Medication non-adherence is a major medical
and public health concern globally. The World Health
Organization defines medical adherence as “the extent
to which a person's behaviour corresponds with agreed
recommendations from a health care provider.”1 The
reported rate of non- adherence varies widely in different
studies from 10% to 92%.2 Among patients with chronic
illness, approximately 50% do not take medications
as prescribed.1 A large body of literature reveals that
non-adherence in patients leads to poor therapeutic
outcomes, substantial worsening of disease, higher
patient mortality and increased health care costs.3-5
Medication-taking behaviour is complex and
individual. It is the result of an interplay of numerous
patient, physician, medication and health care systemrelated
factors6,7 Obstacles to medication adherence
include inadequate knowledge about a drug and its use,
not being convinced of the need for treatment, fear of
adverse effects of the drug, long term drug regimens,
poly-pharmacy and complex drug regimens.8 On the
other hand, providing useful prescription information to
improve understanding of drug treatment is an important
way to ensure optimal medication use.9-11
A quantitative survey revealed that, despite more
easy access to health information using internet,
health professionals are still regarded as the most
reliable sources of drug information.12 Besides, the
quality of information and how patients perceive them
constitute other important determinants for the eventual
medication-taking behaviour.13
The primary objective of this study was to
investigate patients’ sources of drug information and
how patients perceived the usefulness of the information.
As drug compliance can have a s significant impact on
the outcome of chronic illnesses, we would investigate
how the perception of drug information would affect
drug compliance with chronic medications. We hope the
results would inform clinicians in pursuing strategies
for effective delivery of drug information as a way to
optimise the use of medications, hence promoting a
better health outcomes for patients.
Methods
This was a cross sectional study conducted by
means of a questionnaire survey. It was approved by the
Ethics Committee of the Department of Health, HKSAR
on 4 July 2018.
We conducted the study in six primary care (outpatient)
clinics among sampled subjects aged 18
or above who had attended the clinic for a medical
consultation during a period from 3 September 2018 to
29 March 2019.
Daily patient appointment record in each clinic
would form a list for sample selection each day during
the study period. Each appointment record contained the
number of appointment slots equivalent to the number
of available quotas for that day. Each appointment slot
was numbered.
In selecting subjects, three numbers from each
clinic were identified each day using the random number
table. The corresponding subject in the appointment slot
would be recruited for the study. Trained counter staff
would invite them to participate in the study upon their
presentation at the reception counter. If the subject was
below the age of 18, the one in the next appointment
slot would be invited. No substitution would be
arranged for subjects who refused to participate.
A self-administered questionnaire in Chinese
or English where appropriate, was distributed to the
sampled subjects by the counter staff. Nurses taking
charge of the study was responsible for collecting the
questionnaires upon its completion. If necessary, they
would also assist with questionnaire completion. For
subjects with special needs such as hearing and speech
difficulties or for those who could not communicate
in Cantonese, Putonghua or English, assistance from
their accompanying household members/caregivers
to facilitate completion of this study was allowed.
All sampled subjects were, at the beginning of the
interview, informed of the nature and purpose of the
survey, voluntary participation, and anonymity as
well as confidentiality of information collected. They
were asked to give verbal consent before proceeding
and were informed that agreement to or decline to
participating in this study did not affect the services
provided to them by the clinic.
The questionnaire consisted of 33 questions
(Annexes), which covered demographics (Q1-7), healthseeking
pattern (Q8-9), medical illnesses (Q10), drug
compliance rate (Q11), sources of drug information
(Q16), views (Q12-15, Q17-18, Q32-33) and perception
of drug information, e.g. easy to understand or not,
useful or not (Q19-31). Subjects were encouraged
to answer all questions relevant to them. There were
instructions on the questionnaire to guide subjects on
how to skip a certain question(s) if not relevant to
them and to continue with the remaining questions. For
example, if they did not have any illnesses that would
require regular follow up / treatment, they were asked
to skip question 10 and go directly to question 11 after
question 9. In data analysis, the base number for each
question was generated according to the actual number
of responses to that question. Take question 10 as an
example, which asked whether one had any chronic
illnesses, 762 out of 2,165 subjects had skipped that
question as they did not have chronic illnesses; the base
number for that question would be 1,403.
A series of quality control measures were adopted to
ensure that all data collected from the study would be of
satisfactory quality. Training before the study, and further
training sessions during the study if necessary, were
arranged to provide solutions to the difficulties encountered
by the counter staff and nurses. Nurses would check
the questionnaire completed by the participants for its
completeness and dubious responses to individual questions
such as gender or age mismatch, if any. Clarification
with the participants would be made on the spot once
such dubious entries were identified. Furthermore, about
15% of the questionnaires would be checked against
the corresponding data inputted into the computer.
The questionnaires were anonymous. All
questionnaires filled with data and data files were
regarded as confidential documents, and the study team
would exercise due care in its handling. All the data
collected from the study was used for research and
statistical purposes only. All questionnaires filled with
respondents’ information would be destroyed within six
months after completion of the survey.
Statistical analysis
It was proposed to enumerate a random sample
of patients, after balancing the level of precision of
estimates required, the resources and time constraints.
Taken response rate of 90% based on previous studies
with a similar design performed by our team 14,
the proposed sample size of 2,300 was considered
adequate to achieve a precision level with an estimated
sampling error within ±5 percentage points with a 95%
confidence level.
As for data analysis, descriptive analysis was
performed for all questions. Pearson’s Chi-squared
test or Fisher’s exact test (if expected cell count was
less than 5), would be performed to evaluate the
association between the reported drug compliance rate
and other relevant independent variables pertaining
to demographics (Q1-7), views (Q12-15, Q32) and
perception of drug information (Q19-31). Logistic
regression analysis would be performed to adjust the
confounding effect between variables. P-value <0.05 was regarded as statistically significant.
Results
During the study period, a total of 2,365
subjects were invited, 2,165 agreed and returned the
questionnaires, giving the response rate of 91.5%.
The base number for each question was generated
according to the actual number of responses to that
question. Missing data were excluded from analysis,
they accounted for <1% of all responses. The base
number would be stated if it was different from 2,165.
Among the participants, 47% (1,018) were males,
and 71.4% (1,546) were aged above 50 years. About half
of the participants (50.3%, 1,088/2,161) were working at
the time of study. Among the non-working population,
majority of them (67.8%, 725/1,070) were retired,
followed by housewife (30.0%, 321/1,070), unemployed
(1.4%, 15/1,070), student (0.6%, 6/1,070), and others
(0.3%, 3/1,070). As for education level, 49.8%
(1,077/2,161) completed secondary education and 40.7%
(879/2,161) attained tertiary education or above. Table 1
showed the socio-demographic variables of the subjects.
About participants’ health-seeking behaviour,
86.7% (1,874/2,162) would seek doctor’s advice when
feeling unwell, 37.7% (814/2,162) would consume over-the-counter
western medications and 24.0% (518/2,162)
would seek Chinese practitioners’ advice. As for the
frequency of seeing doctors, 64.9% (1,404/2,163)
visited the doctor at least 4 times per year, and 13.8%
(298/2,163) more than 10 times per year.
About their health status, 63.6% (1,378/2,165) had
at least one chronic illness that required regular follow
up, mostly hypertension (58.4%, 805/1,378), followed
by hyperlipidaemia (22.2%, 306/1,378) and diabetes
mellitus (21.1%, 291/1,378).
Regarding the views on drug information, 91.9%
(1,985/2,160) strongly agreed/ agreed that drug
information is necessary, and 90.7% (1,959/2,160)
strongly agreed/agreed that provision of drug
information makes one more likely to use medications
according to doctor’s advice. On the other hand, 73.0%
(1,576/2,160) strongly agreed/ agreed that information
about untowards effects of drugs would adversely affect
their drug-taking decision.
As for the source of drug information, 81.5%
(1,757/2,156) regarded doctors as the most important
source of information to them, followed by pharmacists/
dispensers (47.8%, 1,030/2,156), drug information
leaflets in clinic (32.4%, 699/2,156), and nurses (20.5%,
443/2,156). Besides, 17.3% (372/2,156) of subjects
regarded the internet as the most important source of
drug information.
About the type of drug information that was
considered most important, 80.2% (1,722/2,147) were
concerned about side effects of medications, followed
by 56.1% (1,205/2,147) about how to administer the
drug and 41.9% (899/2,147) about drug efficacy. About
the type of medications that most concerned them,
73.5% (1,587/2,158) were about antibiotics, 66.0%
(1,425/2,158) about steroids, and 54.8% (1,183/2,158)
about chronic medications.
When given drug information leaflet, only 37.7%
(814/2,158) would always/ often read it. For those who
had read the drug leaflet, 64.3% (1,215/1,889) strongly
agreed/ agreed that it is easy to understand and 82.4%
(1,556/1,889) strongly agreed/ agreed that it is useful.
Logistic regression showed there was statistically
significant association between reading drug information
leaflet and good drug compliance (81-100%) for episodic
illnesses (p = 0.000; OR 1.88, 95% CI 1.27-2.78).
During doctor’s consultation, 10.6% (228/2,147)
were always given drug information, 21.8% (467/2,147)
often, 52.2% (1,120/2,147) sometimes and 15.5%
(332/2,147) were never given drug information. If given
drug information by doctors, 80.8% (1,473/1,824) strongly
agreed/ agreed that it is easy to understand, and 90.2%
(1,646/1,825) strongly agreed/ agreed that it is useful.
During drug collection, 70.7% (1,527/2,159)
strongly agreed/ agreed that drug information given by
pharmacists/ dispensers is adequate, 75.4% (1,627/2,158)
strongly agreed/ agreed that the information is easy to
understand, and 83.2% (1,796/2,158) strongly agreed/
agreed that it is useful.
Regarding the frequency of searching drug
information by internet, 16.4% (355/2,161) always/
often searched internet for drug information, 53.0%
(1,146/2,161) sometimes did so and 30.5% (660/2,161)
never did so. For those who had searched internet for
drug information, 36.0% (539/1,499) strongly agreed/
agreed that it is reliable, 54.8% (822/1,499) were
neutral, and 9.2% (138/1,499) disagreed/ strongly
disagreed it is reliable. As for whether the internet
information is useful or not, 52.9% (793/1,500) strongly
agreed/ agreed that it is useful, and 44.3% (665/1,500)
is neutral and 2.8% (42/1,500) disagreed/ strongly
disagreed it is useful.
Having received different drug information from
other sources, 58.4% (1,261/2,159) of subjects would
continue to adhere to doctor’s advice in taking the
medications, 40.1% (865/2,159) would sometimes stop
the medications, and 1.5% (33/2,159) would always/
often stop taking it.
We define good drug compliance as 81-100%
adherence to the doctors’ recommendations. Overall,
66.9% (1,432/2,141) reported good drug compliance in
episodic illnesses (Table 2a), and 74.3% (993/1,336) in
chronic illnesses (Table2b).
For analysis of drug compliance rate in chronic
illnesses, logistic regression showed good drug
compliance was associated with tertiary education
(p = 0.007, OR 2.17, 95% CI 1.28-3.69) often/always
received drug information during clinic visit (p = 0.000;
OR 2.08, 95% CI 1.22-3.54 and OR 6.09, 95% CI
2.37-15.63 respectively), and agreement that drug
information improves medication- taking behaviour
(p = 0.027, OR 1.90, 95% CI 1.08-3.35) (Table 3).
On the other hand, the drug compliance rate was
not shown to be associated with the perception of
whether or not drug information received was useful or
easy to understand (Table 4).
Regarding the internet as a source of drug
information, there were no statistically significant
associations between drug compliance and frequency of
searching the internet, or perceptions whether or not the
internet is true and reliable, easy to understand or useful.
Discussion
The study recruited 2,165 subjects from 6 clinics
over 7 months. By analysing data collected from selfadministered
questionnaires, we examined patients’
sources of drug information, views and perceptions of drug
information and the relationship with drug compliance.
We found that there was a strong agreement that
drug information is important in improving patients’
compliance to prescribed drug treatment. Doctors were
far regarded as the most important source of drug
information, and the information was perceived with
the highest rate of understandability and usefulness
when compared with pharmacists/ dispensers, drug
information leaflets, nurses and internet. Our findings
were similar to a quantitative survey which revealed
that, despite more easy access to health information
using internet, health professionals are still regarded as
the most reliable sources of drug information.12
Doctors, being the most reliable and trustful source
of drug information to patients, however, were not
able to deliver drug information at every consultation.
Our results showed that only 32.4% of subjects always
or often received drug information from doctors
during consultation. One of the reasons might be time
limitations. The participating clinics provided both
episodic and chronic care. The average consultation
time for each patient was around 5-10 minutes. Doctors
often had to manage multiple problems with different
degrees of complexity within a single consultation
session. Therefore, drug information might be more
often given to those patients with special needs such as
elders, pregnant women, etc, or when prescribing special
groups of medications such as antibiotics and steroids.
It is encouraging that when given drug information
by doctors, most subjects were able to understand and
found them useful. Distribution of preset drug leaflets
in consultation might be a practical way to enable
doctors to deliver drug information in a busy practice.
It is intriguing that although drug leaflet was
regarded as the third important source of drug
information and were generally regarded as easy to
understand and useful, only 37.7% would always/ often
read them if they were available in clinic. When we
examined the health-seeking pattern of participants,
we found that 65% of them visited doctor at least 4
times per year, and 14% even more than 10 times per
year. It might be possible that subjects had repeatedly
come across the same set of drug information leaflets in
clinic over the year. Besides, 64% of participants had at
least one chronic illness that required regular follow up.
They might already be using the medications for quite
some time. The accumulated knowledge and experience
with the use of these medications might diminish their
interest in reading drug leaflets. As echoed by other
studies, patients’ needs and quest for information
will change over time in response to their personal
experiences with the medications.15 Drug information
leaflets might need to cover a wide range of different
medications, particularly those most concerned e.g.
antibiotics, steroids, and chronic medications. They
have to be updated regularly to keep abreast of new
developments and knowledge and in keeping with the
needs, preferences, and drug use experience of people.
The widespread use of the internet as an
information source has aroused active concerns from
health professionals.16,17 It has been reported that 80%
of adult internet users have accessed it for general
health information and 36% of them specifically for
medication information.18 It is noteworthy that the
highly variable and uncontrolled quality of health
information in the world wide web has been shown to
cause adverse outcomes.17
Similarly, 70% of our subjects would at least
sometimes searched the internet for drug information.
Fortunately, only one-third of them believed the
information was reliable and the perception of the
usefulness of internet information was much lower
than that provided by doctors’, pharmacists’/dispensers’
or drug information leaflets’. The reason might be
the participants were generally more mature. Seventy
percent of them were above 50 years old and over 90%
had attained secondary education or above.
The overall rate of good drug compliance was
66.9% for episodic illnesses and 74.3% for chronic
illnesses. Our analysis was more focused on chronic
illnesses because optimal control of which is tied to
improved health outcomes, better survival benefits, and
a more cost-effective health care system.3-5
For participants who agreed that drug information
has bearing on drug adherence, their drug compliance in
chronic illnesses was already better than those who did
not. Furthermore, those having received drug information
were found to be strongly associated with good drug
compliance. Interestingly, we found no significant
relationship between drug compliance and the perception
of whether the drug information was understandable
or useful or not. It was more the act of receiving drug
information from trustful persons, than the process
of understanding that had made the difference in
medication-taking behaviour. This was in line with the
findings that drug compliance was found not associated
with the habit of internet searching or perception of
internet information in this studied population.
Overall, our study suggested more effort should focus
on strategies to enable doctors to deliver drug information,
which should also be targeted and relevant to the needs
of an individual patient. As regards the limitations of the
study, the questionnaire used was not properly validated,
though the process of design did go through repeated
cycles of evaluation and verification by a group of
doctors, pharmacists and statisticians so as to envelop
the most relevant dimensions of the concept under study.
The questions about drug compliance should be based
on more validated tools for measuring drug compliance.
The mean age of our subjects was above 50 years. Most
of them had attained secondary education or above. The
overall characteristics might not be the same as the Hong
Kong population at large. Therefore, the findings might
not be generalisable to all clinic settings. The median age
of the Hong Kong population is around 45 years. Our
population has ease of access to health education through
different means via public and social media. Our results
might be a meaningful reference to other settings as well.
Conclusion
Doctor was regarded as the most important source
of drug information. The information provided was
perceived as easy to understand and useful. Though
the internet was a common way for searching drug
information, the perception of its usefulness was the
lowest. What most concerned patients were the side
effects of medications, how to administer the drug and
drug efficacy, particularly those pertaining to antibiotics,
steroids, and chronic medications. Good drug
compliance was strongly associated with the provision of
drug information, regardless of whether the information
was perceived as understandable or useful or not.
Acknowledgements
We are indebted to colleagues in the Health Statistics
Division, Department of Health for their tremendous
support in the design of the questionnaires and data
analysis of this study. We also thank every doctor, nurse
and clerical colleague in the Team who were involved
in coordinating and conducting data collection. Their
perseverance and dedicated effort have contributed
greatly to the success and publication of this study.
References
-
Sabaté E, editor. , ed. Adherence to Long-Term Therapies: Evidence for
Action. Geneva, Switzerland: World Health Organization; 2003.
-
Grahame-Smith DG, Aronson JK. Oxford Textbook of Clinical Pharmacology
and Drug Therapy. 3rd Edition. Oxford University Press, USA. 2002.
-
DiMatteo MR. Variations in patients’ adherence to medical recommendations:
a quantitative review of 50 years of research. Med Care. 2004;42(3):200–209.
-
IMS Institute for Healthcare Informatics Avoidable costs in US health care. 2013. Available
at: http://offers.premierinc.com/rs/381-NBB-525/images/Avoidable_Costs_in%20_
US_Healthcare-IHII_AvoidableCosts_2013%5B1%5D.pdf (accessed 5 April 2021)
-
DiMatteo MR. Evidence-based strategies to foster adherence and improve
patient outcomes. JAAPA. 2004;17(11):18–21.
-
Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin
Proc. 2011;86:304–314.
-
De Geest S, Sabaté E. Adherence to long-term therapies: Evidence for
action. Eur J Cardiovasc Nurs. 2003;2:323.
-
Leupkar RV. Patient adherence: A "risk factor" for cardiovascular disease.
The Framington Study. JAMA. 1971;215:1617-1625.
-
D. Charvuduka, M. Dzimwasha, F. Madondo, et al. Drug information for
patients in the community. World Health Forum, 1991; 12:29-33.
-
Larsson I, Arvidsson S, Bergman S, et al. Patients’ perceptions of drug
information given by a rheumatology nurse: a phenomenographic study.
Musculoskeletal Care, 2010(Mar);8(1):36-45.
-
US Food and Drug Administration. Center for Drug Evaluation and Research.
Draft guidance: guidance of useful written medication information (CMI).
Available at: https://www.fda.gov/media/72574/download (accessed 5 April 2021)
-
Tresin, VF, Veitch, G Brian. Patient sources of drug information and attitudes to
their provision: a corticosteroid model. Pharm World Sci, 2003. Oct;25(5):191-196.
-
A comparison of patients’ and pharmacists’ satisfaction with medication
counselling provided by community pharmacies: a cross-sectional survey.
BMC Health Services Research BMC series. 201616: 131.
-
Tammy KW Tam, KK Ng, CM Lau, et al. Faecal occult blood screening:
knowledge, attitude, and practice in four Hong Kong primary care clinics.
HKMJ. 2011(Oct);17(5):350-357.
Available at: https://doi.org/10.1186/s12913-016-1374-x (accessed 5 April 2021)
-
van Geffen EC, Philbert D, van Boheemen C, et al. Patients’ satisfaction with
information and experiences with counseling on cardiovascular medication
received at the pharmacy. Patient EducCouns. 2011(June);83(3):303-309.
-
Lindsay F; Midford R; Cooper M. Researching drug information needs in
Australia. Drug Alcohol Rev. 2002(Sept);21(3):287-294.
-
Martin-Facklam M;Kostrzewa M; Martin P; et al. Quality of drug
information on the World Wide Web and strategies to improve pages with
poor information quality. An intervention study on pages about sildenafil.
British Journal of Clinical Pharmacology. 2004(Jan); 57(1):80-85.
-
Fox S, Fallows D. Internet health resources: health searches and email have
become more commonplace, but there is room for improvement in searches
and overall Internet access. Washington, DC: Pew Internet & American Life
Project; 2003. webcite Jul 16.
Available at: https://www.pewresearch.org/internet/2003/07/16/internethealth-
resources/ (accessed 5 April 2021)
Tammy KW Tam,
MB ChB (CUHK), FHKCFP, FRACGP, FHKAM (Family Medicine)
Senior Medical and Health Officer,
Professional Development and Quality Assurance Service, Department of Health,
Hong Kong SAR
Dominic MW Lau,
MB ChB (CUHK), FHKCFP, FRACGP, FHKAM (Family Medicine)
Senior Medical and Health Officer,
Professional Development and Quality Assurance Service, Department of Health,
Hong Kong SAR
Kinson KS Lau,
MB ChB (Lpool), FHKCFP, FRACGP, FHKAM (Family Medicine)
Senior Medical and Health Officer,
Professional Development and Quality Assurance Service, Department of Health,
Hong Kong SAR
Kwok-keung Ng,
MB ChB (CUHK), FHKCFP, FRACGP, FHKAM (Family Medicine)
Consultant,
Professional Development and Quality Assurance Service, Department of Health,
Hong Kong SAR
Cecilia YM Fan,
MBBS (HKU), FHKCFP, FRACGP, FHKAM (Family Medicine)
Consultant in charge,
Professional Development and Quality Assurance Service, Department of Health,
Hong Kong SAR
Correspondence to:
Dr Tammy KW Tam. G/F Maurine Grantham Health Centre, 115
Castle Peak Road, Tsuen Wan, N.T., Hong Kong SAR.
E-mail: tammy_kw1@hotmail.com
|